Experimental group:toripalimab

2 trials

Sponsors

Affiliated Hospital of Qingdao University, Xi'an Jiaotong University Second Affiliated Hospital

Conditions

Clear cell renal carcinomahead and neck squamous cell carcinoma

Phase 2

A phase II neoadjuvant study of teriprizumab maintenance therapy for locally advanced head and neck squamous cell carcinoma after radical concurrent chemoradiotherapy

RecruitingChiCTR2100046422

Affiliated Hospital of Qingdao Universityhead and neck squamous cell carcinoma

Start: 2021-05-20Updated: 2022-01-04

Use of toripalimab as adjutant treatment of high risk clear cell renal carcinoma after radical nephrectomy

RecruitingChiCTR2400092716

Xi'an Jiaotong University Second Affiliated HospitalClear cell renal carcinoma

Start: 2024-05-30Updated: 2024-12-02